Company Profile

Avadel Pharmaceuticals Plc (NASDAQ: AVDL)
4:00 PM EDT, 08/21/19
Last: $2.09 Change: +0.01 %Change: +0.48% Volume: 241,155
Detailed Quote
Open: $ 2.03   Volume: 241,155
High: $ 2.26   Yield(%) n/a
Low: $ 2.03   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 77.70M
EPS ($) n/a   Shares Out: 37.36M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -6.31
% Price Change (last 13 weeks): 41.50
% Price Change (last 26 weeks): -5.02
% Price Change (last 52 weeks): -53.36
% Price Change (year to date): -25.18
Management Effectiveness
Return on Equity (%): -215.48
Return on Assets (%): -42.92
Return on Invested Capital (%): -24.91
Profitability
Gross Profit Margin (%): 76.63
Net Profit Margin (%): -92.29
Operating Profit Margin (%): -58.64
Price & Volume
50-day Moving Average: $2.38
200-day Moving Average: $2.20
Avg. Daily Vol. (last 50 days): 262,827
Avg. Daily Vol. (last 200 days): 230,848
52-wk high: $5.25
52-wk low: $1.03
Bid: $2.09
Ask: $2.32
Company Information
Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. It offers Bloxiverz, Vazculep, and Akovaz. The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.
Avadel Pharmaceuticals Plc
Blanchardstown Corporate Park Block 10-1, 2nd Floor Ballycoolin
Dublin DU 15

Phone: 353.1.485.1200
Fax: 353.1.526.1077
http://www.avadel.com
Per Share Data
Earnings (1year) ($): -2.72
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 0.07
Cash Flow ($): -2.35
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): 0.93
Price/Book (x): 34.63
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 3.13
Current Ratio (x): 3.25
LT Debt/Equity (x): 4163.09
Total Debt/Equity (x): 4166.91



Quotes displayed with 15 minutes delay. Market data provided by ICE Data Services ICE Limitations. Powered and implemented by FactSet. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Hemscott equity data provided by Morningstar, Inc. Earnings Calendar and Events Data provided by Wall Street Horizon. © 2018 Wall Street Horizon, Inc.